Failure of Second-Line Therapy to Modify Survival in Relapsed Squamous Cell Carcinoma of the Head and Neck
Open Access
- 1 August 1985
- journal article
- research article
- Published by SAGE Publications in Tumori Journal
- Vol. 71 (4) , 367-370
- https://doi.org/10.1177/030089168507100408
Abstract
Between August 1979 and August 1984, 47 consecutive patients with recurrent squamous cell carcinoma of the head and neck entered one of three consecutive second-line treatments. Response rates with each treatment were very different (70 % vs 5.9 % vs 75 %), but there was no statistical difference in actuarial survival (survival: 30 % vs 29 % vs 20 %, respectively, at 260 days). In light of this observation, the efficacy of the second-line therapy appears doubtful and the survival of relapsing patients seems unrelated to the response achieved.This publication has 7 references indexed in Scilit:
- Ineffectiveness of 5-Fluorouracil and Cis-Platin as Second-Line Chemotherapy in Head and Neck CancerTumori Journal, 1984
- Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neckCancer, 1984
- Cis-platinum induction chemotherapy in the multi-modality initial treatment of advanced stage IV carcinoma of the head and neckCancer, 1983
- Improved survival for patients with advanced carcinoma of the head and neck treated with methotrexate‐leucovorin prior to definitive radiotherapy or surgery.The Laryngoscope, 1981
- Integration of chemotherapy into a combined modality treatment plan for head and neck cancer: A reviewInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Advanced recurrent squamous cell carcinoma of the head and neck. Results of a chemotherapeutic regimen with adriamycin, bleomycin, 5-fluorouracil, methotrexate, and vitamin ACancer, 1980
- Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II in an effective outpatient scheduleCancer, 1979